Skip to main content

Table 3 Antibodies used for characterization of putative stem/progenitor cell populations within the BMC preparation

From: Safety and feasibility of cell-based therapy of autologous bone marrow-derived mononuclear cells in plate-stabilized proximal humeral fractures in humans

Antigen

Conjugation

Company

Catalog#

Clone

CD34

FITC

BD-Biosciences

555820

581

CD45

PerCP

BD-Biosciences

340665

2D1

CD133

PE

Miltenyi biotech

130-080-801

AC133

CD271

APC

Miltenyi biotech

130-091-884

ME20.4-1.H4